CEREVEL THERAPEUTICS HLDNG I's ticker is and the CUSIP is 15678U908. A total of 5 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,800,975 | -25.8% | 82,500 | +8.1% | 0.00% | 0.0% |
| Q2 2023 | $2,425,577 | -38.1% | 76,300 | -52.5% | 0.00% | -50.0% |
| Q1 2023 | $3,917,034 | +60.7% | 160,600 | +107.8% | 0.00% | +100.0% |
| Q4 2022 | $2,438,042 | -34.6% | 77,300 | -41.4% | 0.00% | -50.0% |
| Q3 2022 | $3,727,000 | +1499.6% | 131,900 | +1398.9% | 0.00% | – |
| Q2 2022 | $233,000 | – | 8,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 182,000 | $3,973,060 | 0.01% |
| SIMPLEX TRADING, LLC | 83,800 | $1,829 | 0.00% |
| JANE STREET GROUP, LLC | 82,500 | $1,800,975 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |